Intermediate Level – Listed Assessed Medicines

Reform recommendations for complementary medicines has seen the development of a three-tiered, risk-based framework for the regulation of CAM’s. The revised framework introduces a new (intermediate risk) assessment pathway sitting between the existing listed medicine (low risk) and registered medicine (high risk) pathways.

At present, listed comple